Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients.
Tsang
W K
WK
Department of Medicine, Princess Margaret Hospital, Hong Kong.
Ho
Y W
YW
Tong
K L
KL
Chan
W H
WH
Chan
A
A
D000328:Adult; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004304:Dosage Forms; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D012044:Regression Analysis; D013997:Time Factors
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine